The estimated Net Worth of Heidi C. Chen is at least $11 Milion dollars as of 10 February 2024. Ms. Chen owns over 5,277 units of Zoetis Inc stock worth over $6,151,686 and over the last 12 years she sold ZTS stock worth over $4,875,973. In addition, she makes $0 as Executive Vice President, General Counsel oraz Corporate Secretary at Zoetis Inc.
Heidi has made over 35 trades of the Zoetis Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently she exercised 5,277 units of ZTS stock worth $1,002,577 on 10 February 2024.
The largest trade she's ever made was exercising 37,453 units of Zoetis Inc stock on 20 February 2018 worth over $1,156,923. On average, Heidi trades about 2,517 units every 34 days since 2013. As of 10 February 2024 she still owns at least 32,379 units of Zoetis Inc stock.
You can see the complete history of Ms. Chen stock trades at the bottom of the page.
Heidi C. Chen serves as Executive Vice President, General Counsel, Corporate Secretary of Zoetis Inc. Ms. Chen has served as our Executive Vice President and General Counsel since October 2012, and as our Corporate Secretary since July 2012. Ms. Chen was also given responsibility for our Human Health Diagnostics business in January 2020. Prior to Zoetis, Ms. Chen was Vice President and Chief Counsel of Pfizer Animal Health, our predecessor company, from 2009 to 2012. Ms. Chen joined Pfizer in 1998 and held various legal and compliance positions of increasing responsibility, including lead counsel for Pfizer’s Established Products (generics) business.
Heidi Chen is 53, she's been the Executive Vice President, General Counsel oraz Corporate Secretary of Zoetis Inc since 2012. There are 17 older and 6 younger executives at Zoetis Inc. The oldest executive at Zoetis Inc is William Steere, 83, who is the Independent Director.
Heidi's mailing address filed with the SEC is C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY, NJ, 07054.
Over the last 12 years, insiders at Zoetis Inc have traded over $876,669,659 worth of Zoetis Inc stock and bought 1,602,140 units worth $77,083,975 . The most active insiders traders include Square Capital Management, ..., Frank A Damelio oraz Michael B Mccallister. On average, Zoetis Inc executives and independent directors trade stock every 14 days with the average trade being worth of $14,414,921. The most recent stock trade was executed by Soria Ester Banque on 31 July 2024, trading 895 units of ZTS stock currently worth $170,041.
Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.
Zoetis Inc executives and other stock owners filed with the SEC include: